Nicholas Santillan, Author at Ming Hsieh Institute - Page 2 of 4

The Geochemistry of Cancer: A New Collaborative Approach for Research and Diagnosis

Investigators: Seth John; Peter Kuhn; Jorge Nieva; Josh West; Will Berelson

Pilot feasibility study to evaluate the immunomodulatory effects of FID-007 at two dose levels in patients with solid tumors

Investigators: Anthony El-Khoueiry; Jacob Thomas; Stan Louie; Alan Epstein

First Small Molecule Therapy for Retinal Degenerations

Investigators: Mark Humayun; Stan Louie

In Vivo Validation of a Smart Hydrocephalus Shunt

Investigators: Ellis Meng; Gordon McComb

Next Generation CD19 CAR-T for the treatment of lymphoid malignancies

Investigators: Preet Chaudhary; Jianming Xie

Immunomodulatory and Cytotoxic Micelles for Prostate Cancer

Investigators: Eun Ji Chung; Mitchell Gross; Kian Kani; Keyue Shen

Chimeric Antigen Receptor Engineered Natural Killer Cells as a Carrier of Drug-Encapsulated Nanoparticles Targeting Adenosine Receptors in Ovarian Cancer

Investigators: Pin Wang; James Hu

Characterizing the immune microenvironment of lymphoma and myeloma using multiplexed imaging mass cytometry

Investigators: Akil Merchant; Kevin Kelly; Wendy Cozen; James Hicks; Peter Kuhn; Imran Siddiqi

Next Generation CD19 CAR-T for the treatment of lymphoid malignancies

Investigators: Preet Chaudhary; Jianming Xie

Integrating Spatiotemporal Single Cell Proteogenomics Data from Liquid Biopsies in Patients with Head and Neck Cancer

Investigators: Yan Liu; Peter Kuhn; James Hicks; Jorge Nieva